To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations

INTRODUCTION: Lung cancer is one of primary cancer type with high incidence and mortality, non-small cell lung cancer (NSCLC) is the most common type of lung cncer. For advanced lung cancer, traditional chemotherapy and targeted therapy become difficult to solve the dilemma of further progress. In r...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Ruoxue, Zhu, Hongyu, Liu, Ying, Sha, Huanhuan, Peng, Weiwei, Yin, Rong, Zhou, Guoren, Fang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423141/
https://www.ncbi.nlm.nih.gov/pubmed/37261523
http://dx.doi.org/10.1007/s00432-023-04919-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423141/
https://www.ncbi.nlm.nih.gov/pubmed/37261523
http://dx.doi.org/10.1007/s00432-023-04919-4

Ejemplares similares